(Q34112983)

31 July 2017

title

Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle (English)

1 reference

31 July 2017

S Oger

1

1 reference

31 July 2017

D Behr-Roussel

2

1 reference

31 July 2017

D Gorny

3

1 reference

31 July 2017

T Lebret

4

1 reference

31 July 2017

P Validire

5

1 reference

31 July 2017

X Cathelineau

6

1 reference

31 July 2017

L Alexandre

7

1 reference

31 July 2017

F Giuliano

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

British Journal of Pharmacology

31 July 2017

language of work

1 reference

31 July 2017

volume

160

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1135-1143

1 reference

Lower urinary tract symptoms revisited: a broader clinical perspective

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Characterization and functional role of androgen-dependent PDE5 activity in the bladder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

The neurovascular mechanism of clitoral erection: nitric oxide and cGMP-stimulated activation of BKCa channels

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Potency, selectivity, and consequences of nonselectivity of PDE inhibition

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Mechanisms of action of PDE5 inhibition in erectile dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Nitric oxide and the lower urinary tract: current concepts, future prospects.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Influence of nitric oxide signalling pathways on pre-contracted human detrusor smooth muscle in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Nitric oxide and relaxation of pig lower urinary tract

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Inhibition of Human Detrusor Contraction by a Urothelium Derived Factor

5 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Sildenafil inhibits duodenal contractility via activation of the NO-K+ channel pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Sodium nitroprusside-induced rat fundus relaxation is ryanodine-sensitive and involves L-type Ca2+ channel and small conductance Ca(2+)-sensitive K+ channel components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Effects of nitric oxide on the Ca2+-activated potassium channels in smooth muscle cells of the human corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Chronic treatment with a PDE5 inhibitor increases contractile force of normal bladder in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Ca2+-activated K+ (KCa) channels are involved in the relaxations elicited by sildenafil in penile resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Role of nitric oxide in the relaxation elicited by sildenafil in penile resistance arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Role of nitric oxide/cyclic GMP pathway in regulating spontaneous excitations in detrusor smooth muscle of the guinea-pig bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Guide to Receptors and Channels (GRAC), 4th Edition

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936023

Vardenafil Improves Urodynamic Parameters in Men With Spinal Cord Injury: Results From a Single Dose, Pilot Study

28 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1476-5381.2010.00748.X

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue

21 January 2018

1 reference

12 December 2020

Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction

1 reference

12 December 2020

Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder

1 reference

12 December 2020

Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms

1 reference

12 December 2020

Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition

1 reference

12 December 2020

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

12 December 2020

Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization

1 reference

12 December 2020

Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder

1 reference

12 December 2020

10.1111/J.1476-5381.2010.00748.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference